Preliminary Outcomes of Sacral Neuromodulation Applications; Tertiary-Center Experience in Turkey

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

16 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-01-01

Study Completion Date

2023-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

to report our patients' outcomes of SNM in tertiary health centres in Turkey

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Sacral Neuromodulation in Patients With Double Incontinence

NCT07212387

Double Incontinence Faecal Incontinence Urinary Incontinence

NOT_YET_RECRUITING NA

Sacral Stimulation in Women With Low Back Pain: Effects on Pelvic Functions and Daily Life

NCT07094698

Pelvic Floor Dysfunction Low Back Pain

ACTIVE_NOT_RECRUITING NA

The Effects of Sacral Neuromodulation for Urinary Urgency, Frequency, and Urge Incontinence

NCT02776475

Urinary Urge Incontinence

TERMINATED NA

Long Term Efficacy of Sacral Nerve Modulation (SNM) in Patients With Constipation or Stool Incontinence

NCT02836717

Constipation Fecal Incontinence

COMPLETED

Efficacy of Sacral Nerve Modulation on Urinary and Defecation Dysfunction After Spinal Cord Injury：A Prospective, Single-arm Study

NCT06553469

Cystometry Sacral Neuromodulation Ultrasound

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

We retrospectively analyzed 18 patients who underwent SNM for urinary or bowel dysfunction between 2017 and 2022 in our clinic. We excluded 2 patients due to non-effective responses after the test period. After local ethics committee approval was obtained from our institute (Number and date: 21-12.1T/14). Patient characteristics and demographic data including age, gender, indications to the SNM, age at diagnosis, and comorbidities were collected from our Hospital patients' record system. Urinary functions were evaluated by the ICIQ-SF questionnaire form. Patients' diagnosis, implantation duration, complications, and improvement of symptoms were recorded.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sacral Neuromodulation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

sacral neuromodulation

sacra neuromodulator implantation outcomes

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients diagnosed with urinary incontinence
* Patients diagnosed with faecal incontinence
* Patients diagnosed with interstitial cystitis

Exclusion Criteria

* Presence of urinary infection
* Presence of previous incontinence surgery
* Presence of 2nd motor neurone disease
* Inability of detrusor muscle contraction activity
* Previous radical cystoprostatectomy history
* Presence of bladder outlet obstruction

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No